T-cell Activation

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

T-cell Activation

Dec 21, 2024, 18:46 | Insight

Marengo Initiated Phase 2 Trial of Invikafusp Alfa for PD-1 Resistant Tumors, Expands to Europe

Marengo Therapeutics, Inc., a clinical-stage biotechnology company focused on precision T cell activation, has announced…

Nov 9, 2024, 12:04 | Insight

Celebrating 40 Years of TCR Discovery: A Gathering of Giants in T Cell Immunology

This year marks the 40th anniversary of the discovery of the T cell receptor (TCR),…

Jun 22, 2024, 12:27 | Drugs

Chibuike Okafor: Tacrolimus - Beyond Breast Cancer

Chibuike Okafor, Research Assistant at Department of Pharmaceutical/Medicinal Chemistry University of Jos, shared on LinkedIn: "Tacrolimus:…

All: 3 Posts: 1 - 100

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

'

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023